Q1 2017 13F Holders as of 3/31/2017
-
Type / Class
-
Equity / Common Stock, $0.01 par value per share
-
Shares outstanding
-
49.7M
-
Number of holders
-
293
-
Total 13F shares, excl. options
-
46.7M
-
Shares change
-
+3.73M
-
Total reported value, excl. options
-
$4.2B
-
Value change
-
+$352M
-
Put/Call ratio
-
1.23
-
Number of buys
-
134
-
Number of sells
-
-152
-
Price
-
$89.95
Significant Holders of CHARLES RIVER LABORATORIES INTERNATIONAL, INC. - Common Stock, $0.01 par value per share (CRL) as of Q1 2017
327 filings reported holding CRL - CHARLES RIVER LABORATORIES INTERNATIONAL, INC. - Common Stock, $0.01 par value per share as of Q1 2017.
CHARLES RIVER LABORATORIES INTERNATIONAL, INC. - Common Stock, $0.01 par value per share (CRL) has 293 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 46.7M shares
of 49.7M outstanding shares and own 93.99% of the company stock.
Largest 10 shareholders include VANGUARD GROUP INC (5.03M shares), BlackRock Inc. (3.85M shares), FMR LLC (2.49M shares), ARIEL INVESTMENTS, LLC (2.06M shares), STATE STREET CORP (1.24M shares), AQR CAPITAL MANAGEMENT LLC (1.11M shares), RENAISSANCE TECHNOLOGIES LLC (1.07M shares), MILLENNIUM MANAGEMENT LLC (1.02M shares), Bank of New York Mellon Corp (940K shares), and ACADIAN ASSET MANAGEMENT LLC (901K shares).
This table shows the top 293 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.